Meeting the Challenge: Neuroscience Drug Discovery with the Warren Center

Lawrence Marnett, Dean of Basic Sciences at the School of Medicine and Mary Geddes Stahlman Professor of Cancer Research, invites you to Meeting the Challenge: Discovery of new therapeutic agents for treatment of brain disorders in the Warren Center for Neuroscience Drug Discovery.

Vanderbilt panel:

Jeff Conn
Lee E. Limbird Professor in Pharmacology, Director, Warren Center for Neuroscience Drug Discovery

Craig Lindsley
William K. Warren, Jr. Professor in Medicine, University Professor of pharmacology, biochemistry, and chemistry

The Warren Center for Neuroscience Drug Discovery (WCNDD) extends traditional academic pursuits in basic science to take the most exciting advances in our understanding of human disease and drug targets to a point where these breakthroughs can directly impact patient care. This is especially true in discovery of new treatment strategies for the most serious of brain disorders, such as Alzheimer's disease, Parkinson's disease, schizophrenia, autism, and others. By incorporating the highest level of drug discovery into academic research, the WCNDD takes scientific breakthroughs beyond the lab and toward the development of patentable and marketable drugs suited for clinical studies.

Conn and Lindsley give an overview of WCNDD, their neuroscience research and describe the impact of the transformative gift from The William K. Warren Foundation.

Recorded: August 4, 2020